These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 876955)

  • 21. [Electrophysiologic actions of mexiletine (Kö-1173) in man].
    González Maqueda I; García Fernández F; Martín Jadraque L
    Med Clin (Barc); 1981 Mar; 76(5):223-5. PubMed ID: 7206892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of propranolol and practolol on exercise-induced changes in the dynamics of left ventricle contractions].
    Goch JH
    Wiad Lek; 1974 Jan; 27(2):119-22. PubMed ID: 4600841
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
    Sami M; Lisbona R
    Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of parenteral and oral mexiletine.
    Renard M; de Hemptinne J; Gillet JM; Bernard R
    Acta Cardiol Suppl; 1980; (25):75-80. PubMed ID: 6966455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of propranolol, quinidine and lidocaine on spike and plateau potentials of canine ventricular muscle].
    Inagaki T
    Jpn Circ J; 1971 Nov; 35(11):1509-22. PubMed ID: 5172357
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of antifibrillatory agents and catecholamines by a physiologic method.
    Wax SD; Webb WR; Ecker RR; Sugg WL
    Surg Forum; 1968; 19():149-51. PubMed ID: 5718593
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrophysiological effects of mexiletine in man.
    Roos JC; Paalman DC; Dunning AJ
    Postgrad Med J; 1977; 53 Suppl 1():92-6. PubMed ID: 876958
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mexiletine therapy of ventricular extrasystoles in the acute phase of myocardial infarction].
    Juillard A; Bouajina A; Barrillon A; Gay J; Gerbaux A
    Ann Cardiol Angeiol (Paris); 1984; 33(2):117-20. PubMed ID: 6201121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of beta adrenergic blockade in coronary insufficiency. II. Left ventricle dynamics in exertion modified by propranolol and the combination of propranolol and nitroglycerin].
    Lichtlen P; Albert H; Spiegel M
    Z Kreislaufforsch; 1970 Mar; 59(3):207-18. PubMed ID: 4990823
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Clinical electrophysiological effects of mexiletine and its mechanism of antidysrhythmic action.
    McComish M; Crook B; Kitson D; Jewitt D
    Br Heart J; 1976 Mar; 38(3):311. PubMed ID: 1259850
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigation of the antifibrillatory activity of some anticonvulsant gamma-aminobutyric acid-transaminase inhibitors in the rabbit isolated heart: comparison with phenytoin and mexiletine.
    Almotrefi AA; Baker JB
    Br J Pharmacol; 1980; 71(2):635-9. PubMed ID: 7470766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic effects of a new anti-arrhythmia agent: mexiletine].
    Tomassetti V; Fontana F; Masi M; Mezzetti A; Poggiopollini G; Cuppini A; Cuccurullo F
    Boll Soc Ital Cardiol; 1980; 25(1):95-100. PubMed ID: 7236434
    [No Abstract]   [Full Text] [Related]  

  • 35. Explanation for the discrepancy in reported cardiac electrophysiological actions of diphenylhydantoin and lignocaine.
    Singh BN
    Br J Pharmacol; 1971 Feb; 41(2):385P-386P. PubMed ID: 5572288
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemodynamic and electrophysiological effects of intravenous injection of mexiletine].
    Tanaka T; Kusumoto M; Umemura J; Miyazawa Y; Suwa J; Komatsu Y
    Kokyu To Junkan; 1983 Dec; 31(12):1355-60. PubMed ID: 6676806
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical electrophysiological effects of mexiletine.
    McComish M; Kitson D; Robinson C; Jewitt DE
    Postgrad Med J; 1977; 53 Suppl 1():85-91. PubMed ID: 876957
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute effects of anti-arrhythmic drugs on cardiac pacing threshold.
    Mohan JC; Kaul U; Bhatia ML
    Acta Cardiol; 1984; 39(3):191-201. PubMed ID: 6331697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Effects of propranolol on left ventricular function segmental wall motion and diastolic compliance in man.
    Coltart DJ; Alderman EL; Robison SC; Harrison DC
    Br Heart J; 1974 Apr; 36(4):404. PubMed ID: 4842638
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mexitil (Mexiletine). A new antiarrhythmic agent].
    Bjerregaard P
    Ugeskr Laeger; 1980 Oct; 142(43):2855-6. PubMed ID: 7445202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.